Baxter Healthcare (BAX): Rasio utang jangka dawa marang modal

Lambang korporat lan logo Baxter International (BAX)

Baxter International (BAX) CEO Jose Almeida is reorganizing the asset structure by spinning off the nephrology segment to optimize debt. Baxter International (BAX) leverages its status as a global leader in hospital system supplies, creating significant barriers to entry for new industry players. Market price action on GURU.Markets, where the indicator stands at 1.23, confirms steady demand for dialysis consumables, while restructuring costs are already priced into the securities.

Baxter Corp (BAX): Utang jangka dawa marang modal saka 04.07.2022 nganti 28.10.2026
Produk merek baxter.com

The scalable ecosystem of Baxter International (BAX), based on the supply of consumables for medical equipment, requires stable funding to maintain operational leverage. By analyzing the long-term debt-to-equity ratio, an investor assesses the proportion of loans with maturities exceeding one year relative to equity, which allows for the distinction between organic growth and hazardous borrowing. The trend for this metric reveals hidden asset freeze risks and confirms the resilience of the company's financial strategy.

Pesaing langsung

Kewajiban jangka dawa marang modal Intuitive Surgical, Inc.|Utang jangka dawa marang modal Danaher Corp DHR|Rasio utang jangka dawa marang modal Becton Dickinson & Company (BDX)|Utang jangka dawa marang modal STE|Rasio tanggungan utang jangka dawa marang modal westpharma.com WST|MASI: Utang jangka dawa marang modal|STVN - Rasio utang jangka dawa marang ekuitas|TFX: Utang jangka dawa marang modal|MMSI (Merit Medical Corp) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Envista Holdings|Utang jangka dawa marang ekuitas icumed.com (ICUI)|Dentsply Sirona (XRAY) - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal LeMaitre Vascular Inc (LMAT)|Utang jangka dawa marang modal ATRC|STAAR Surgical Co - Rasio tanggungan utang jangka dawa marang modal|ChromaDex Corp. (NAGE) - Utang jangka dawa marang ekuitas|ZIMV: Rasio utang jangka dawa marang modal|AngioDynamics - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Cerus Corp.|Alpha Teknova Inc (TKNO) - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal MGRM|Sharps Technology, Inc. (STSS) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal infusystem.com INFU|Rasio utang jangka dawa marang ekuitas UTMD (Utah Medical Products, Inc.)|KORU Medical Systems, Inc. - Utang jangka dawa marang modal|NYXH: Utang jangka dawa marang ekuitas|MBOT - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal PDEX|ZTEK (zentek.com) - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Elutia (ELUT)|Rasio utang jangka dawa marang modal Milestone Scientific Inc (MLSS)|Rasio utang jangka dawa marang ekuitas NEXGEL, Inc|Rasio silihan jangka dawa marang modal RVP (retractable.com)|Utang jangka dawa marang ekuitas HBIO|Rasio tanggungan utang jangka dawa marang modal femasys.com FEMY|MHUA - Utang jangka dawa marang modal|POAI - Utang jangka dawa marang ekuitas|CJMB: Utang jangka dawa marang modal|Utang jangka dawa marang modal Atrion Corporation Inc.|Rasio utang jangka dawa marang ekuitas NeuroMetrix, Inc. (NURO)